Hemoglobin A(1c) assays and hemoglobinopathies: Problems and strategies;Dosage de l'hemoglobine A(1c) et hemoglobinopathies : Problemes poses et conduite a tenir

Annales de Biologie Clinique

Volumn 58, Issue 4, 2000, Pages 425-430

  Gillery, R ^a   Hue, G ^a   Bordas Fonfrede, M ^a   Chapelle, J P ^a   Drouin, P ^a   Levy Marchal, C ^a   Perier, C ^a   Selam, J L ^a   Slama, G ^a   Thivolet, C ^a   Vialettes, B ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

Assays; Diabetes mellitus; HbA(1c); Hemoglobinopathies; Interferences

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

BLOOD ANALYSIS; GLYCATION; HEMOGLOBIN DETERMINATION; HEMOGLOBINOPATHY; HUMAN; RETROSPECTIVE STUDY; REVIEW; ARTIFACT; BLOOD; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEMOLYSIS; METABOLISM; METHODOLOGY; REPRODUCIBILITY;

ARTIFACTS; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINOPATHIES; HEMOLYSIS; HUMANS; REPRODUCIBILITY OF RESULTS;

EID: 0033838298     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Marqueurs de la glycation des proteines dans le depistage du diabete: Applications aux populations a forte prevalence d'hemoglobinopathies
2. Kinetic analysis of the nonenzymatic glycosylation of hemoglobin
3. A glucose transfer from membrane glyconjugates to haemoglobin in isolated red blood cells: Another biosynthetic way for glycosylated haemoglobins
4. Use of the HbA(1c) determinations as long-term parameter in diabetes control
5. Observations on the decay of glycated hemoglobin HbA(1c) in diabetic patients
6. Appreciation de la duree de vie des globules rouges par le dosage de l'hemoglobine glycosylee: Interet clinique
7. Amadori rearrangement potential of hemoglobin at its glycation sites is dependent on the three-dimensional stucture of protein
8. Glycosylation of hemoglobin S and hemoglobin C
9. Glycation of hemoglobin C in the heterozygous state in diabetic patients
10. Hemoglobin Rambam (β69 [E13] Gly → Asp), a pitfall in the assessment of diabetic control: Characterization by electrospray mass spectrometry and HPLC
11. Chromatographic and electrophoretic methods for modified hemoglobins
12. Hemoglobin Raleigh (β1 valine → acetylalanine): Structural and functional characterization
13. Hemoglobin Raleigh as the cause of a falsely increased hemoglobin A(1c) in an automated ion-exchange HPLC
14. A nondiabetic case of hemoglobin variant (Hb Niigata) with inappropriately high and low HbA(1c) titers detected by different methods
15. Influence of hemoglobin variants and derivatives on glycohemoglobin determinations, as investigated by 102 laboratories using 16 methods
16. HbE(1c) as an indicator for the presence of HbAE phenotype in diabetic patients
17. Spuriously elevated hemoglobin A(1c) in a diabetic patient with two rare hemoglobin variants (hemoglobin Raleigh and hemoglobin Russ)
18. Effects of sickle cell trait and hemoglobin C trait on determination of HbA(1c) by an immunoassay method
19. Glycated haemoglobin (HbA(1c)) measurements in subjects with haemoglobin variants, using the DCA 2000
20. Detection fortuite d'anomalies de l'hemoglobine lors du dosage de l'hemoglobine glyquee par une technique de chromatographie liquide haute pression
21. Hemoglobin Dominion/Burton-upon-Trent, β143(H21) His → Tyr, codon 143 CAC → TAC - A variant with altered oxygen affinity that compromises measurement of glycated hemoglobin in diabetes mellitus: Structure, function and DNA sequence
22. Glycohemoglobin assays evaluated in a large-scale quality control survey
23. Evaluation of glycohemoglobin assays in France by national quality control surveys
24. Hb Les Andelys [α83(F4) Leu → Pro]: A new moderately unstable variant
25. Hemoglobin D [β121(GH4) Glu → Gln] causing falsely low and high HbA(1c) values in HPLC
26. Glycohemoglobin results in samples with hemoglobin C or S trait: A comparison of four test systems
27. Hemoglobine glyquee: Le temps de la standardisation est venu
28. Hemoglobins S and C: Reference values for glycohemoglobin in heterozygous, double-heterozygous and homozygous subjects, as established by 13 methods
29. β-N-terminal glycohemoglobins in subjects with common hemoglobinopathies: Relation with fructosamine and mean erythrocyte age
30. Combined use of a fasting plasma glucose concentration and HbA(1c) or fructosamine predicts the likehood of having diabetes in high-risk subjects
31. Comparison of serum fructosamine vs glycohemoglobin as measures of glycemic control in a large diabetic population
32. Recommandations pour le dosage des proteines glyquees par la methode dite des fructosamines
33. Standardisation du dosage des fructosamines